dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Hernando Cubero, Jorge |
dc.contributor.author | Alonso, Lola |
dc.contributor.author | Fasani, Roberta |
dc.contributor.author | Jiménez Flores, José Antonio |
dc.contributor.author | Elez Fernandez, Mª Elena |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Nuciforo, Paolo Giovanni |
dc.contributor.author | Capdevila Castillon, Jaume |
dc.contributor.author | Landolfi, Stefania |
dc.contributor.author | Comas Navarro, Raquel |
dc.contributor.author | Ruiz Pace, Fiorella |
dc.contributor.author | Serna, Garazi |
dc.contributor.author | Dienstmann, Rodrigo |
dc.date.accessioned | 2021-10-04T12:58:49Z |
dc.date.available | 2021-10-04T12:58:49Z |
dc.date.issued | 2020-10 |
dc.identifier.citation | Serna G, Ruiz-Pace F, Hernando J, Alonso L, Fasani R, Landolfi S, et al. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer. Ann Oncol. 2020 Oct;31(10):1366–75. |
dc.identifier.issn | 0923-7534 |
dc.identifier.uri | https://hdl.handle.net/11351/6378 |
dc.description | Fusobacterium nucleatum; Càncer de recte avançat local; Quimioteràpia preoperatòria |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Annals of Oncology;31(10) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Bacteris gramnegatius |
dc.subject | Recte - Càncer - Quimioteràpia |
dc.subject | Recte - Càncer - Radioteràpia |
dc.subject.mesh | Rectal Neoplasms |
dc.subject.mesh | Fusobacterium nucleatum |
dc.subject.mesh | Chemoradiotherapy |
dc.title | Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.annonc.2020.06.003 |
dc.subject.decs | neoplasias del recto |
dc.subject.decs | Fusobacterium nucleatum |
dc.subject.decs | quimiorradioterapia |
dc.relation.publishversion | https://doi.org/10.1016/j.annonc.2020.06.003 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Serna G, Alonso L, Fasani R, Jimenez J, Nuciforo P] Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ruiz-Pace F, Comas R, Dienstmann R] Oncology Data Science Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Hernando J, Elez E, Capdevila J] Servei d’Oncologia Mèdica, Unitat de Tumors gastrointestinals i endocrins, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Landolfi S] Servei d’Anatomia Patològica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Tabernero J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain |
dc.identifier.pmid | 32569727 |
dc.identifier.wos | 000574680100001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |